Harbin, China

Haisong Jiang

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Cosci Med-Tech Co. Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haisong Jiang. Retrieved from https://idiyas.com/inventor/haisong-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haisong Jiang: Innovator in Controlled Porous Osmotic Pump Tablets

Introduction

Haisong Jiang is a notable inventor based in Haerbin, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of controlled drug delivery systems. His innovative work focuses on enhancing the efficacy of high permeable drugs through advanced tablet formulations.

Latest Patents

Haisong Jiang holds a patent for "Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof." This invention relates to a novel approach for creating controlled porosity in osmotic pump tablets without the need for laser drilling. By incorporating a suitable quantity of pore-forming agents into the semipermeable membrane, the tablets allow for controlled drug release. Specifically, this invention includes formulations comprising venlafaxine or metoprolol, or their pharmaceutically acceptable salts.

Career Highlights

Haisong Jiang is associated with Cosci Med-tech Co. Ltd., where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in drug delivery systems, making medications more effective and accessible to patients.

Collaborations

Haisong Jiang collaborates with Jingang Wang, further enhancing the research and development efforts within their field. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Haisong Jiang's contributions to the development of controlled porous osmotic pump tablets represent a significant advancement in pharmaceutical technology. His innovative approach to drug delivery systems has the potential to improve patient outcomes and revolutionize the way medications are administered.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…